[A response to erlotinib hydrochloride in the case of post-operative recurrent thymoma].
A 43-year-old female was diagnosed with a recurrence of thymoma 6 years after the operation. Eight kinds of systemic chemotherapy were undergone for over 6 years. As the 9th chemotherapy, erlotinib hydrochloride was prescribed and the tumor decreased in size about 8 weeks later.
Dept. of Respiratology, Kyoundo Hospital.
Eisuke
E
Takahashi
Haruya
H
Koshiishi
Masayoshi
M
Takahashi
D000328:Adult; D000069347:Erlotinib Hydrochloride; D005260:Female; D006801:Humans; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D011799:Quinazolines / Q000627:therapeutic use*; D012008:Recurrence; D013945:Thymoma / Q000188:drug therapy* / Q000473:pathology; D013953:Thymus Neoplasms / Q000188:drug therapy* / Q000473:pathology
D047428:Protein Kinase Inhibitors; D011799:Quinazolines; D000069347:Erlotinib Hydrochloride